A new drug target for chronic pain relief subject of 2013 lecture
November 7, 2013
WEST LAFAYETTE, Ind. — Potential new treatments for inflammatory and neuropathic pain is the subject of a talk by a member of the Medicinal Chemistry Hall of Fame at the Varro E. Tyler Distinguished Lecture on Friday (Nov. 8) at Purdue University.
Philip S. Portoghese, a distinguished professor in the Department of Medicinal Chemistry at the University of Minnesota, Twin Cities, will discuss a promising target for the treatment of chronic, unmanageable pain in his presentation "Targeting Putative MOR-mCluR5 Heteromer in the Design of Highly Effective Analgesics for Treatment of Pain Arising from Tissue or Nerve Damage" at 10:30 a.m. in the Lawson Computer Science Building, Room 1142.
Portoghese's research has focused on novel concepts to design biologically active compounds, and he has designed opioid painkillers that are effective without the adverse effects of morphine and related analgesics. He also was editor-in-chief of the Journal of Medicinal Chemistry, the most highly cited journal in the field, from 1972-2011 and is the recipient of research awards from national and international scientific societies. More information about Portoghese is available at http://www.pharmacy.purdue.edu/tyler/speaker.php.
The Varro E. Tyler Distinguished Lecture series honors the late Varro E. Tyler, who was dean of the College of Pharmacy from 1966-1987, for his many contributions to the development of professional and research programs. Virginia Tyler, the College of Pharmacy, and the Department of Industrial and Physical Pharmacy are lecture sponsors.
More information is available at http://www.pharmacy.purdue.edu/tyler/ or by contacting Dana Neary, College of Pharmacy manager of alumni relations and special events, at nearyd@purdue.edu, 765-494-2632.
Writer: Elizabeth K. Gardner, 765-494-2081, ekgardner@purdue.edu
Source: Dana Neary, 765-494-2632, nearyd@purdue.edu
